While it is difficult to know the exact sequence of events during activation of human SOX9 in vivo, analysis of H3K27ac enhancer ChIP indicated that these three enhancer regions are active in an embryonic testis carcinoma cell line, NT2-D1. Here, SOX9 is linked to testicular embryonal carcinoma.